diphenidine: a psychoactive substance with dissociative effects; structure in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
| ID Source | ID |
|---|---|
| PubMed CID | 206666 |
| CHEMBL ID | 4303426 |
| CHEBI ID | 104234 |
| SCHEMBL ID | 3715253 |
| MeSH ID | M000608048 |
| Synonym |
|---|
| BRD-A86415025-103-01-7 |
| CHEBI:104234 |
| 1-(1,2-diphenylethyl)piperidine |
| 36794-52-2 |
| SCHEMBL3715253 |
| diphenidine |
| h8q4vpl82y , |
| unii-h8q4vpl82y |
| piperidine, 1-(1,2-diphenylethyl)- |
| J2.366.921H , |
| DTXSID50724547 |
| 1-(1,2-diphenyl-ethyl)piperidine |
| Q15708284 |
| BRD-A86415025-050-01-0 |
| CHEMBL4303426 |
| (+)-1-(1,2-diphenylethyl)piperidine |
Diphenidine is a dissociative drug that shows several psychotropic effects including euphoria, shifts in perception of reality, hallucinations, and transient anterograde amnesia.
| Excerpt | Reference | Relevance |
|---|---|---|
| "Diphenidine is a dissociative drug that shows several psychotropic effects including euphoria, shifts in perception of reality, hallucinations, and transient anterograde amnesia. " | ( A Case of Nonfatal Intoxication Associated with the Recreational use of Diphenidine. Bovetto, E; Corcia, DD; Gerace, E; Salomone, A; Vincenti, M, 2017) | 2.13 |
| "Diphenidine is a new psychoactive substance (NPS) sold as a 'legal high' since 2013. " | ( Diphenidine, a new psychoactive substance: metabolic fate elucidated with rat urine and human liver preparations and detectability in urine using GC-MS, LC-MS Jacobsen-Bauer, A; Maurer, HH; Michely, JA; Wink, CS; Zapp, J, 2016) | 3.32 |
| Class | Description |
|---|---|
| stilbenoid | Any olefinic compound characterised by a 1,2-diphenylethylene backbone. |
| [compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res] | |
| Timeframe | Studies, This Drug (%) | All Drugs % |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 14 (87.50) | 24.3611 |
| 2020's | 2 (12.50) | 2.80 |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be strong demand-to-supply ratio for research on this compound.
| This Compound (39.84) All Compounds (24.57) |
| Publication Type | This drug (%) | All Drugs (%) |
|---|---|---|
| Trials | 0 (0.00%) | 5.53% |
| Reviews | 0 (0.00%) | 6.00% |
| Case Studies | 3 (16.67%) | 4.05% |
| Observational | 1 (5.56%) | 0.25% |
| Other | 14 (77.78%) | 84.16% |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||